Annexin Pharmaceuticals AB (OSTO:ANNX) Cyclically Adjusted FCF per Share: kr-94.99 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:ANNX Annexin Pharmaceuticals AB OSTO:ANNX
19 GF Score
Price kr13.00
! 1 Warning Sign
View Full Analysis

What is Annexin Pharmaceuticals AB Cyclically Adjusted FCF per Share?

Annexin Pharmaceuticals AB OSTO:ANNX +0.39% 19 Cyclically Adjusted FCF per Share is kr-94.99 as of Mar. 2026. GuruFocus rates OSTO:ANNX with a GF Score™ of 19/100. The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Annexin Pharmaceuticals AB's adjusted free cash flow per share for the three months ended in Mar. 2026 was kr-1.441. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is kr-94.99 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-07-17), Annexin Pharmaceuticals AB's current stock price is kr13.00. Annexin Pharmaceuticals AB's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was kr-94.99. Annexin Pharmaceuticals AB's Cyclically Adjusted Price-to-FCF of today is .


Annexin Pharmaceuticals AB  (OSTO:ANNX) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Annexin Pharmaceuticals AB Cyclically Adjusted FCF per Share Related Terms


Annexin Pharmaceuticals AB Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Annexin Pharmaceuticals AB's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Annexin Pharmaceuticals AB Cyclically Adjusted FCF per Share Chart

Annexin Pharmaceuticals AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -179.19

Annexin Pharmaceuticals AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -183.76 -179.19 -94.99

OSTO:ANNX vs VRTX, REGN, ALNY: Cyclically Adjusted FCF per Share Comparison

For the Biotechnology subindustry, Annexin Pharmaceuticals AB's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Annexin Pharmaceuticals AB Cyclically Adjusted Price-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Annexin Pharmaceuticals AB's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Annexin Pharmaceuticals AB's Cyclically Adjusted Price-to-FCF falls into.


OSTO:ANNX
19GF Score
Annexin Pharmaceuticals AB OSTO:ANNX
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Annexin Pharmaceuticals AB Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Annexin Pharmaceuticals AB's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-1.441/133.5600*133.5600
=-1.441

Current CPI (Mar. 2026) = 133.5600.

Annexin Pharmaceuticals AB Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 -88.000 101.019 -116.347
201609 -58.033 101.138 -76.637
201612 -42.231 102.022 -55.286
201703 -141.794 102.022 -185.628
201706 -60.462 102.752 -78.590
201709 -49.826 103.279 -64.435
201712 -53.565 103.793 -68.927
201803 -47.777 103.962 -61.379
201806 -30.393 104.875 -38.706
201809 -12.436 105.679 -15.717
201812 -9.534 105.912 -12.023
201903 -13.408 105.886 -16.912
201906 -11.301 106.742 -14.140
201909 -9.054 107.214 -11.279
201912 -12.924 107.766 -16.017
202003 -5.344 106.563 -6.698
202006 -8.312 107.498 -10.327
202009 -6.106 107.635 -7.577
202012 -8.547 108.296 -10.541
202103 -10.142 108.360 -12.501
202106 -8.013 108.928 -9.825
202109 -5.025 110.338 -6.083
202112 -3.993 112.486 -4.741
202203 -4.031 114.825 -4.689
202206 -4.058 118.384 -4.578
202209 -2.906 122.296 -3.174
202212 -4.142 126.365 -4.378
202303 -3.940 127.042 -4.142
202306 -2.750 129.407 -2.838
202309 -3.697 130.224 -3.792
202312 -3.276 131.912 -3.317
202403 -3.848 132.205 -3.887
202406 -2.657 132.716 -2.674
202409 -2.708 132.304 -2.734
202412 -2.239 132.987 -2.249
202503 -1.228 132.825 -1.235
202506 -1.589 133.699 -1.587
202509 -1.408 133.480 -1.409
202512 -1.412 133.390 -1.414
202603 -1.441 133.560 -1.441

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of kr-94.99 mean?
Annexin Pharmaceuticals AB (OSTO:ANNX) has a Cyclically Adjusted FCF per Share of kr-94.99 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Annexin Pharmaceuticals AB and its competitors.
Is Annexin Pharmaceuticals AB's Cyclically Adjusted FCF per Share too high?
Annexin Pharmaceuticals AB's current Cyclically Adjusted FCF per Share is kr-94.99. Overall, Annexin Pharmaceuticals AB has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Annexin Pharmaceuticals AB's Cyclically Adjusted FCF per Share compare to VRTX and REGN?
Annexin Pharmaceuticals AB's Cyclically Adjusted FCF per Share of kr-94.99 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Biotechnology company?
A good Cyclically Adjusted FCF per Share depends on the Biotechnology industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Annexin Pharmaceuticals AB and its competitors. Annexin Pharmaceuticals AB's current Cyclically Adjusted FCF per Share is kr-94.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Annexin Pharmaceuticals AB stock overvalued right now?
Annexin Pharmaceuticals AB (OSTO:ANNX) has a current Cyclically Adjusted FCF per Share of kr-94.99. The current Cyclically Adjusted FCF per Share is kr-94.99. Annexin Pharmaceuticals AB's overall GF Score™ is 19/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Annexin Pharmaceuticals AB (OSTO:ANNX), the current Cyclically Adjusted FCF per Share is kr-94.99 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Annexin Pharmaceuticals AB Business Description

Other Exchanges Q910:Germany
Address Kammakargatan 48, Stockholm, SWE, 111 60
Annexin Pharmaceuticals AB is a biotechnology company. It is developing biological drug candidate ANXV, a recombinant human protein Annexin A5 for treatment of various cardiovascular diseases. The company also focuses on development of ANXV for the treatment of retinal vein occlusion.
19GF Score

Get the complete analysis for OSTO:ANNX

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr13.00
Price